期刊文献+

不同化疗药物对人肝癌BEL-7404细胞端粒长度的影响

Effects of chemotherapeutic drugs with different dose on telomere length of BEL-7404 cells
下载PDF
导出
摘要 目的观察不同浓度几种化疗药物对人肝癌BEL-7404细胞端粒长度的影响。方法采用Southern Blot-ting及凝胶电泳法测定不同化疗药物对人肝癌BEL-7404细胞端粒限制片断长度(TRF)变化影响。结果TRF随化疗药物浓度的增加而逐渐缩短:低浓度组(A、B组)中DDP,MMC,ADM对BEL-7404细胞表现出明显的抑制性,与对照组比较有统计学差异(P<0.05);VCR对BEL-7404细胞的端粒长度均不具抑制性。高浓度组(C组)DDP、ADM、MMC、VCR中的平均TRF与对照组比较均有统计学差异,与低浓度组比较进一步缩短(P<0.05)。结论上述药物对端粒的抑制作用呈浓度效应关系。 Objective To investigate the effects of chemotherapeutic drugs with different dose on telomere length (TRF) of BEL-7404 cells. Methods TRF was examined by the method of southern blotting and gel electrophoresis. Resuits The TRF shortened gradually with the increasing of the concentration of chemotherapeutic drugs : The significant inhibiting activity of DDP, MMC and ADM on BEL-7404 cells was shown in group A and B with significant difference compared with control group (P 〈 0.05 ), while VCR had no inhibiting activity. There were significant difference in average TRF between group C treated with DDP, MMC, ADM, VCR and the normal control group (P 〈0.01 ) . The TRF in group C shortened significantly compared with A and B group (P 〈 0.05) . Conclusions The drugs mentioned above have the inhibiting effect with concentration dependent.
出处 《山东医药》 CAS 北大核心 2009年第48期12-13,共2页 Shandong Medical Journal
基金 广西卫生厅科技攻关项目(桂科自0229040)
关键词 肝细胞 BEL-7404 端粒 端粒限制片断 carcinoma, hepatocellular BEL-7404 telomere telomere restriction fragments
  • 相关文献

参考文献2

二级参考文献19

  • 1[1]Blackburn EH.Telomerase:noend in sight[J].Cell,1994,7:621-623.
  • 2[2]Z,hang W,Kapusta LR,Slingefiand JM,et al.Telomerase activity in prostate cancer,prostatic intraepthelial neoplasia,and benign prostatic epithelium.[ J ].Cancer Res,1998,58:619.
  • 3[3]Rhysu MS.Telomeres,telomerase,and immortality.J Natl Cancer Inst,1995,87:884-894.
  • 4[4]Hiyama E,Yokoyama T,Tatsumoto N,et al.Telomerase activity in gastric cancer[ J ].Cancer Res,1995,55(15):3258-3262.
  • 5[5]Counter CM,Hirte HW,Bacchettis,et al.Telomerase activity in human ovarian carcinoma[J].Proc Natl Acad Sci USA,1994,91:2900.
  • 6[6]Zheng PS,lwasaka T,Yamaski F,et al.Telomerase activity in gyn ecologic tumors [ J ].Gynecol Oncol,1997,64:171.
  • 7[7]Yoshida K,Sugino T,Goodison S,et al.Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related chinical implication[ J].Br J Cancer,1997,75:548-553.
  • 8[8]Murakami J,Nagai N,Ohama K,et al.Telomerase activity in ovarian tumors[ J ].Am cancer Society,1997,6:1085-1091.
  • 9[9]Xu YH,Ma GZ,Li SR,et al.Telomerase activity expression in the diseases of cervices[ J ].Chinese Journal of Obstetrics and Gynecology,2000,7:35.
  • 10[1]Greider CW.Blackbum EH.Telomerase biochemistry and regulation in cellular immortalization [J].Proc Am Assoc Cancer Res,1995,36:672.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部